The National Cancer Institute (NCI) is offering this grant, CUSP2CT, to increase the referral and ultimate accrual of underrepresented racial/ethnic minority populations into NCI-supported cancer clinical trials. This initiative aims to address cancer health disparities by funding the implementation and evaluation of multilevel, culturally tailored outreach and education interventions. Applicants should establish multidisciplinary partnerships with community health educators, healthcare providers, and researchers. These collaborations will educate and refer minority populations, while also increasing awareness among providers about R/E minority participation. The program expects grantees to identify and overcome local barriers and facilitators to trial participation, ensuring underrepresented groups have greater access to vital cancer research opportunities.
Opportunity ID: 336246
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-21-063 |
| Funding Opportunity Title: | A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 21, 2021 |
| Last Updated Date: | Oct 21, 2021 |
| Original Closing Date for Applications: | Dec 10, 2021 |
| Current Closing Date for Applications: | Dec 10, 2021 |
| Archive Date: | Jan 15, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $450,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Special district governments Independent school districts Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) solicits applications for Connecting Underrepresented Populations to Clinical Trials (CUSP2CT), a program that will implement and evaluate multilevel and culturally tailored outreach and education interventions with the primary goal of increasing referral and ultimately, accrual of underrepresented racial/ethnic (R/E) minority populations, to NCI-supported clinical trials (CTs) (National Clinical Trial Network (NCTN), NCI’s Community Oncology Research Program (NCORP), and Experimental Therapeutics Clinical Trials Network (ETCTN)). The target population(s) should include individuals from underrepresented racial/ethnic (R/E) minority populations. Applicants should address cancer health disparities (CHD) through a network of local multidisciplinary and integrated partners that include community health educators (CHEs), lay health advisors (LHAs), community members, healthcare providers, and researchers working in coordination to educate and refer R/E minority populations to NCI-supported CTs, and increase awareness in providers about R/E minority participation in NCI clinical trials. This will require outreach and education multilevel interventions at the CT site, provider, and/or patient levels. The proposed interventions should be informed by relevant theories, frameworks, or models and guided by preliminary data and/or the sufficient infrastructure in place and expertise on the local contextual barriers and facilitators for increasing CT referral of R/E minority population. It is expected that U01 grantees will establish partnerships with the community, primary care providers, and other stakeholders to enhance identification of R/E minority referral barriers and facilitators to NCI-supported CTs. A companion funding opportunity (see U24 funding opportunity RFA-CA-21-058) will support a Data, Evaluation and Coordinating Center (DECC) that will provide experienced project |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-063.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00269435 | Nov 10, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00270434 | Nov 18, 2021 | Dec 10, 2021 | View |
Package 1
Mandatory forms
336246 RR_SF424_2_0-2.0.pdf
336246 PHS398_CoverPageSupplement_5_0-5.0.pdf
336246 RR_OtherProjectInfo_1_4-1.4.pdf
336246 PerformanceSite_2_0-2.0.pdf
336246 RR_KeyPersonExpanded_2_0-2.0.pdf
336246 PHS398_ResearchPlan_4_0-4.0.pdf
336246 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
336246 RR_Budget_1_4-1.4.pdf
336246 RR_SubawardBudget30_1_4-1.4.pdf
336246 PHS398_ModularBudget_1_2-1.2.pdf
336246 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
336246 RR_SF424_5_0-5.0.pdf
336246 PHS398_CoverPageSupplement_5_0-5.0.pdf
336246 RR_OtherProjectInfo_1_4-1.4.pdf
336246 PerformanceSite_4_0-4.0.pdf
336246 RR_KeyPersonExpanded_4_0-4.0.pdf
336246 PHS398_ResearchPlan_4_0-4.0.pdf
336246 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
336246 RR_Budget_3_0-3.0.pdf
336246 RR_SubawardBudget30_3_0-3.0.pdf
336246 PHS398_ModularBudget_1_2-1.2.pdf
336246 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
